Meglitinides

SZ 363 Pill - yellow capsule-shape

Pill with imprint SZ 363 is Yellow, Capsule-shape and has been identified as Repaglinide 2 mg. It is supplied by Sandoz Inc.

Repaglinide is used in the treatment of Diabetes, Type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Repaglinide (Repaglinide (oral) [ re-pag-li-nide ])-SZ 363-2 mg-Yellow-Capsule-shape

Repaglinide
Generic Name: repaglinide (oral) [ re-pag-li-nide ]
Imprint: SZ 363
Strength: 2 mg
Color: Yellow
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Meglitinides
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00781-5150 (Discontinued)
Inactive Ingredients: Corn starch, Calcium phosphate dibasic anhydrous, Glycerin, Magnesium stearate, Meglumine, Microcrystalline cellulose, Poloxamer 188, Polacrilin potassium, Magnesium silicate, Ferric oxide yellow,
Latest News
Related Drugs